Xzom
- Diagnostics
- Medical device or technology
- Other products or services
- Other R&D services
- Synthesis, analytic, diagnostic services
- Academic, tech transfer
Xzōm – Early Enough.
Xzōm is pioneering the future of early disease detection through its proprietary liquid biopsy platform, which leverages on-chip exosome analysis to deliver clinical-grade diagnostic results in 30 minutes or less. Designed for rapid, point-of-care testing, Xzōm’s technology empowers timely and accurate detection across a broad range of applications including oncology, neurological conditions, infectious diseases, and beyond.
With a mission to make lifesaving diagnostics accessible and affordable for all, Xzōm is shifting the healthcare paradigm—from reactive, late-stage intervention to proactive, early-stage detection. By enabling providers and patients to act earlier, Xzōm is helping unlock better outcomes and a more efficient, equitable healthcare system.
Address
San DiegoCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}